Company Filing History:
Years Active: 1980-1985
Title: The Innovative Mind of Georg Feth
Introduction
Georg Feth, an accomplished inventor based in Schaffhausen, Switzerland, has made significant contributions to the field of chemical synthesis. With a total of three patents to his name, Feth's work exemplifies innovation and dedication to improving processes in the pharmaceutical industry.
Latest Patents
Feth's latest patents reflect his expertise in synthetic organic chemistry. One of his notable inventions is a process for the preparation of substituted formamidine. This involves a multi-step reaction, beginning with the formation of a complex between dimethylformamide and dimethyl sulfate, followed by reactions with n-octylamine and optionally with dimethylamine. The process concludes with treating the reaction mixture with aqueous base to yield N,N-dimethyl-N'-octyl-formamidine, which can then be reacted with 4-(diphenylmethyl) piperidine to produce the compound 4-(diphenylmethyl)-1-[(octylimino)methyl]piperidine without the need for further purification.
Additionally, he developed compounds within the class of 1-(2-oxysubstituted-3-anilinopropyl)-imidazoles, which exhibit antimicrobial activity, showcasing his contributions to healthcare.
Career Highlights
Throughout his career, Georg Feth has worked with prominent companies in the industry, including Cilag International GmbH and McNeil AB. His work at these organizations has undoubtedly shaped his expertise and led him to develop his innovative patents.
Collaborations
Feth's journey was enriched by collaborations with talented individuals like Carl Richter and John E. Mills. Working alongside these professionals, Georg has been able to advance his research and contribute further to the field of chemistry.
Conclusion
Georg Feth is a testament to the innovative spirit in the realm of chemical inventions. His patents demonstrate not only his technical skills but also his commitment to improving chemical processes for practical applications. As research continues to evolve, Feth's contributions will remain integral in shaping future developments in the pharmaceutical industry.